Status:
COMPLETED
Plantar Fasciopathy and the Effectiveness of Radial Extracorporeal Shockwave Therapy, Physical Training or Usual Care
Lead Sponsor:
Oslo University Hospital
Conditions:
Plantar Fascitis
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate whether radial extracorporeal shockwave therapy (rESWT), sham- rESWT or standardised exercise program is more effective on change in heel pain than usual care ...
Detailed Description
Plantar fasciopathy is a common cause of plantar heel pain, with reported lifetime prevalence up to 10%. The choice of best practice in these patients is debated. Two randomised studies reported that ...
Eligibility Criteria
Inclusion
- Pain with duration \> 3 months localized in the proximal insertion of the plantar fascia on the medial calcaneal tuberosity.
- Only patients with reported pain NRS 3 or more at activity at baseline, will be included in the trial.
- Tenderness to palpation corresponding to the painful area.
- Be residents of Norway, understand oral and written Norwegian.
Exclusion
- Treatment with radial extracorporeal shock wave therapy the last 3 months.
- Spondylarthropathy or rheumatoid arthritis.
- Plantar fibromatosis.
- Tarsal tunnel syndrome.
- Polyneuropathy.
- Previous surgery with remaining osteosynthesis material in the foot or ankle.
- Contraindications for shock wave therapy ( use of anticoagulant drugs, pregnancy, bleeding disorders, epilepsy or pacemaker)
Key Trial Info
Start Date :
March 21 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 22 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03472989
Start Date
March 21 2018
End Date
February 22 2023
Last Update
March 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital, Ullevål
Oslo, Norway, 0450